Doctors pioneer heart surgery breakthrough

June 19, 2012
Professor Ian Meredith

(Medical Xpress) -- The first trial of a treatment allowing doctors to insert a fully repositionable replacement heart valve without the need for open-heart surgery has been successfully conducted at a Melbourne hospital.

Doctors at the Monash Medical Centre heart unit, known as MonashHeart, saved the lives of 11 who were suffering from aortic stenosis, the degrading and narrowing of the main heart valve.

A team of and surgeons, led by MonashHeart director Professor Ian , inserted a replacement heart valve, on the end of a wire, through a small hole in the groin of the women, who were too frail to undergo the invasive open-heart surgery often given to younger patients with the condition.

Dubbed a ‘lotus valve’, the valve opens up like a flower once inside the heart, and can be easily repositioned. The trial, which reported a 100 per cent success rate, promises to help save the lives of senior patients around the world.

Professor Meredith, from the Department of Medicine at Monash University, said the prognosis for elderly patients was usually about the same as people with advanced forms of cancer.

"When you have severe aortic valve narrowing and you become breathless as a consequence of that, more than half the people won't survive 12 months," Professor Meredith said.

"Only about a third will survive up to two years."

Professor Meredith said he would now lead a wider, international trial of the lotus heart valve device.

"This will have a significant impact on all around the world because this is a very common problem in the elderly," Professor Meredith said.

Sixteen facilities in four countries will take part in the new trial.

The Monash Medical Centre is part the Department of Medicine at Monash University. Established in 2007, MonashHeart is an amalgamation of the former Departments of Cardiology of Monash Medical Centre, Clayton and Dandenong Hospital.

Explore further: Expandable prosthesis resolves advanced aortic valve disease

Related Stories

Recommended for you

No new heart muscle cells in mice after the newborn period

November 5, 2015

A new study from Sweden's Karolinska Institutet shows that new heart muscle cells in mice are mainly formed directly after birth. After the neonatal period the number of heart muscle cells does not change, and A new study ...

Nanotechnology could spur new heart treatment

October 29, 2015

A new nanoparticle developed by University of Michigan researchers could be the key to a targeted therapy for cardiac arrhythmia, a condition that causes the heart to beat erratically and can lead to heart attack and stroke.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.